PHATHOM PHARMACEUTICALS INC Share Price Today: Live Updates & Key Insights

PHATHOM PHARMACEUTICALS INC share price today is $11.43, up 0.54%. The stock opened at $11.285 against the previous close of $11.15, with an intraday high of $11.85 and low of $11.12.

PHATHOM PHARMACEUTICALS INC Share Price Chart

PHATHOM PHARMACEUTICALS INC

us-stock
To Invest in {{usstockname}}
us-stock

PHATHOM PHARMACEUTICALS INC Share Price Performance

$11.43 0.0054(0.54%) PHAT at 23 Mar 2026 02:44 PM Biotechnology
Lowest Today 11.12
Highest Today 11.85
Today’s Open 11.285
Prev. Close 11.15
52 Week High 18.31
52 Week Low 2.21
Day’s Range: Low 11.12 High 11.85
52-Week Range: Low 2.21 High 18.31
1 day return -
1 Week return +7.32
1 month return -1.23
3 month return -37.2
6 month return -4.55
1 year return +71.22
3 year return +75.78
5 year return -74.1
10 year return -

PHATHOM PHARMACEUTICALS INC Institutional Holdings

Frazier Life Sciences Management, L.P. 15.82

Medicxi Ventures Management (Jersey) Ltd 9.47

Amvescap Plc. 4.90

The Carlyle Group Inc 4.44

BlackRock Inc 4.32

Vanguard Group Inc 4.03

Ensign Peak Advisors Inc 2.98

Invesco Global A 2.97

Millennium Management LLC 2.64

Invesco OFI Global Equity 2.51

Vanguard Total Stock Mkt Idx Inv 2.49

NEA Management Company, LLC 2.49

683 Capital Management LLC 2.27

Catalys Pacific LLC 1.81

Wasatch Advisors LP 1.69

GW&K Investment Management, LLC 1.66

Geode Capital Management, LLC 1.36

State Street Corp 1.34

iShares Russell 2000 ETF 1.25

Strategic Advisers U.S. Total Stock 1.15

Wasatch Micro Cap 0.95

Propel Bio Management LLC 0.94

Catalio Capital Management, LP 0.89

AZ InvestEd Ivy Small Cap Growth E 0.85

Moore Capital Management, LP 0.76

Ameriprise Financial Inc 0.70

Susquehanna International Group, LLP 0.70

Wasatch Ultra Growth 0.69

Vanguard Institutional Extnd Mkt Idx Tr 0.63

MEDICAL BioHealth EUR Acc 0.55

Fidelity Small Cap Index 0.49

State Street® SPDR® S&P® PhrmctlsETF 0.46

Invesco VI Global I 0.45

iShares Biotechnology ETF 0.43

Simplify Propel Opportunities ETF 0.39

JNL/Invesco Global Growth A 0.37

Franklin Biotechnology Discovery A 0.36

iShares Russell 2000 Value ETF 0.31

BrighthouseI Invesco Global Equity A 0.30

Fidelity Extended Market Index 0.30

PHATHOM PHARMACEUTICALS INC Market Status

Strong Buy: 6

Buy: 2

Hold: 1

Sell: 0

Strong Sell: 0

PHATHOM PHARMACEUTICALS INC Fundamentals

Market Cap 883.33 M

PB Ratio 25.3678

PE Ratio 0.0

Enterprise Value 960.43 M

Total Assets 259.15 M

Volume 2623930

PHATHOM PHARMACEUTICALS INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-177069000 -177.1M, FY22:-223006000 -223.0M, FY21:-148094000 -148.1M, FY20:-133318000 -133.3M, FY19:-209744000 -209.7M

Quarterly Revenue Q3/2025:49504000 49.5M, Q2/2025:39503000 39.5M, Q1/2025:28519000 28.5M, Q3/2024:16352000 16.4M, Q2/2024:7324000 7.3M

Quarterly Profit Q3/2025:43314000 43.3M, Q2/2025:34465000 34.5M, Q1/2025:24795000 24.8M, Q3/2024:13996000 14.0M, Q2/2024:5948000 5.9M

Quarterly Net worth Q3/2025:-29973000 -30.0M, Q2/2025:-75810000 -75.8M, Q1/2025:-94316000 -94.3M, Q3/2024:-85577000 -85.6M, Q2/2024:-91446000 -91.4M

About PHATHOM PHARMACEUTICALS INC & investment objective

Company Information Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Organisation Biotechnology

Employees 371

Industry Biotechnology

CEO Mr. Steven L. Basta M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

PHATHOM PHARMACEUTICALS INC FAQs

What is the share price of PHATHOM PHARMACEUTICALS INC today?

The current share price of PHATHOM PHARMACEUTICALS INC is $11.43.

Can I buy PHATHOM PHARMACEUTICALS INC shares in India?

Yes, Indian investors can buy PHATHOM PHARMACEUTICALS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy PHATHOM PHARMACEUTICALS INC shares in India?

You can easily invest in PHATHOM PHARMACEUTICALS INC shares from India by:

Can I buy fractional shares of PHATHOM PHARMACEUTICALS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of PHATHOM PHARMACEUTICALS INC?

PHATHOM PHARMACEUTICALS INC has a market cap of $883.33 M.

In which sector does PHATHOM PHARMACEUTICALS INC belong?

PHATHOM PHARMACEUTICALS INC operates in the Biotechnology sector.

What documents are required to invest in PHATHOM PHARMACEUTICALS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of PHATHOM PHARMACEUTICALS INC?

The PE ratio of PHATHOM PHARMACEUTICALS INC is N/A and the PB ratio is 25.37.